Boris Peaker, Ph.D., CFA

Managing Director, Health Care - Biotechnology

Headshot photo of Boris Peaker

Boris Peaker is a managing director and senior research analyst covering emerging growth biotechnology companies. Prior to rejoining Cowen in 2014, Dr. Peaker was a senior analyst at Oppenheimer & Co. and Rodman & Renshaw, covering large-, mid-, and small-cap biotechnology stocks. Dr. Peaker holds a BS in physics and chemistry from Stony Brook University and a Ph.D. in biophysics from Stanford University. He is a CFA charterholder. HCBiopharma

Get In Touch

Start a conversation with Boris Peaker

Insights

Explore related thought leadership, reports, coverage and insights for Boris Peaker.

Ahead of the Curve®

An Investor’s Guide to Bispecific Antibodies

Read More
Ahead of the Curve®

Investor’s Guide to Immuno-Oncology: Focus on Novel Targets

Read More
Ahead of the Curve®

The ABCs of ADCs: Investor Primer on Antibody Drug Conjugates

Read More

Research Contacts

Our Research team is led by seasoned, entrepreneurial-minded individuals who are driven by a relentless curiosity to redefine expectations.

Meet Our People
Senior businessman handshaking with young woman in the office